Brokers Offer Predictions for VIR Q1 Earnings
Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) – Equities researchers at HC Wainwright issued their Q1 2026 earnings estimates for shares of Vir Biotechnology in a research note issued on Friday, February 28th. HC Wainwright analyst P. Trucchio anticipates that the company will earn ($0.80) per share for the quarter. HC Wainwright has a “Buy” […]
